Michael Marsh
Neurology with Special Qualifications in Child Neurology · San Antonio, TXNPI 1710243027
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 210 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by UCB, Inc. at 31.3% of the total. 2025 is the largest year on record at $2,395, 8.8 times the $271 reported in 2019.
Across 210 payments — averaging $24.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$2K
- Corium, LLC$500
- Otter Pharmaceuticals, LLC$405
- Livanova USA, Inc.$389
- Jazz Pharmaceuticals Inc.$295
- Acadia Pharmaceuticals Inc$243
- plus $2K from 24 others
What the payments were for
- Food & beverage$5,08499%
- Education$291%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 60 | $1,598 |
| Corium, LLC | 37 | $500 |
| Otter Pharmaceuticals, LLC | 14 | $405 |
| Livanova USA, Inc. | 13 | $389 |
| Jazz Pharmaceuticals Inc. | 9 | $295 |
| Acadia Pharmaceuticals Inc | 8 | $243 |
| Neurelis, Inc. | 7 | $227 |
| Biogen | 2 | $142 |
| Upsher-smith Laboratories LLC | 5 | $127 |
| GSK | 1 | $125 |
| Supernus Pharmaceuticals, Inc. | 8 | $121 |
| Tris Pharma Inc | 4 | $116 |
| Azurity Pharmaceuticals, Inc. | 4 | $111 |
| Catalyst Pharmaceuticals, Inc. | 4 | $94 |
| Shire North American Group Inc | 5 | $85 |
| Zogenix Inc. | 3 | $60 |
| Pyros Pharmaceuticals, Inc. | 2 | $59 |
| AbbVie | 3 | $58 |
| Biocodex, Inc. | 2 | $57 |
| Aucta Pharmaceuticals, Inc. | 7 | $53 |
| Eisai Inc. | 2 | $42 |
| Greenwich Biosciences, Inc. | 2 | $40 |
| Springworks Therapeutics, Inc. | 1 | $34 |
| Aquestive Therapeutics, Inc. | 1 | $25 |
| ITF Therapeutics LLC | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| OWP Pharmaceuticals, Inc. | 1 | $16 |
| Medtronic | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$290
- AREXVY$125
- SHINGRIX$125
- Fintepla$125
- SPINRAZA$122
How this compares
$5,113 in reported general payments places this provider in the 75th percentile of 193 neurology with special qualifications in child neurology providers in Texas.
See all neurology with special qualifications in child neurology providers in Texas →
Other neurology with special qualifications in child neurology in San Antonio
- Carter RichardsSan Antonio$7K
- Jerry TomasovicSan Antonio$5K
- Kelly AverillSan Antonio$5K
- Sheldon GrossSan Antonio$4K
- Roy EltermanDallas$5.9M
- Huda ZoghbiHouston$5.5M
- Diana CastroDenton$343K
- Shade MoodyHouston$194K
- Mary Kay KoenigHouston$171K
- Michael PerryFort Worth$162K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.